Medical News

RSS

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.

26 Oct 2009

Tart cherry juice may help runners recover quickly and effectively from post-race pain

From gold medalists to weekend warriors, athletes at every level are in search of new ways to reduce pain and enhance post-exercise recovery. Recent research shows that drinking tart cherry juice may help runners recover more quickly and effectively from post-race pain.

26 Oct 2009

HealthSouth announces credit agreement amendment and extended maturity of a portion of its term loan

HealthSouth Corporation today announced it has amended its credit agreement and extended maturity of a portion of its term loan. A segment of the lenders under the term loan that has a current outstanding balance of approximately $750 million will extend the maturity for $300 million of that loan from March 2013 to September 2015, contingent on certain conditions.

26 Oct 2009

StayinFront signs agreements with two leading biopharma companies to deploy StayinFront EdgeRx

StayinFront, Inc., a leading global provider of CRM and decision support solutions, announced today that they have reached agreements with two leading biopharma companies to deploy StayinFront EdgeRx. Announced only recently, StayinFront EdgeRx is the new On Demand CRM and analytics solution that offers superior functionality and performance from a company that has been delivering cutting edge CRM solutions to the industry for 20 years.

26 Oct 2009

ADA Technologies to develop home lithiummonitor for patients with bipolar disorder

ADA Technologies, Inc. (ADA) received a $189,886 grant from the National Institute of Mental Health to develop a home lithiummonitor for use by patients with bipolar disorder.

26 Oct 2009

Phase 2a clinical trial in nonsense mutation hemophilia A and hemophilia B initiated

PTC Therapeutics, Inc. (PTC) today announced it is expanding the development of ataluren, an investigational new drug, to a third indication with the initiation of a Phase 2a clinical trial in nonsense mutation hemophilia A (nmHA) and hemophilia B (nmHB).

26 Oct 2009

Ontario Lung Association partners with Health Canada for radon gas awareness campaign

As winter weather approaches and we move activities indoors, it's a good time to think about the quality of the air in our homes. Radon is a colourless, odourless gas that is produced from the natural breakdown of uranium in rocks and soil. Radon can enter a home through tiny openings in floors and foundations and build up to dangerous levels. Long-term exposure to radon is the second leading cause of lung cancer in Canada.

26 Oct 2009

CMSC analyses patient self-management in Multiple Sclerosis

The Consortium of Multiple Sclerosis Centers (CMSC) released a white paper, written by a panel chaired by CMSC member Robert T. Fraser, Ph.D., of the University of Washington Rehabilitation Research and Training Center in Seattle, Washington, analyzing patient self-management in Multiple Sclerosis (MS) to develop recommendations for best practices aimed at improving patients' lives.

26 Oct 2009

Results from Phase I dose-escalation study of AT-101 announced

Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral, pan-Bcl-2 inhibitor, in patients with the most malignant type of brain tumor, were described in an oral presentation at the 2009 Joint Meeting of the Society for NeuroOncology (SNO) and AANS/CNS Section on Tumors in New Orleans, Louisiana (Concurrent Session VI: Radiation Oncology, October 23, 2009; Abstract # 449).

26 Oct 2009

Allegheny Technologies acquires Crucible Compaction Metals and Crucible Research for $40.95 million

Allegheny Technologies Incorporated announced that it has completed the purchase of the assets of Crucible Compaction Metals and Crucible Research for $40.95 million.

26 Oct 2009

Rexahn Pharmaceuticals completes Registered Direct Offering of common stock and warrants

Rexahn Pharmaceuticals, Inc. announced today that it has completed its previously announced Registered Direct Offering of common stock and warrants. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NasdaqGM: RODM), acted as the exclusive placement agent for this transaction.

26 Oct 2009

Dysport, a new wrinkle fighter, available now in the United States

The story: Dysport(TM), a new wrinkle fighter, is now available in the United States. Dysport(TM) is a Botulinum-A enzyme like Botox Cosmetic. Dysport(TM) is positioned as the new arch-nemesis and first direct competitor of Botox Cosmetic in the United States.

26 Oct 2009

HealthSouth to reimburse shareholder expenses for proxy solicitation campaign

HealthSouth Corporation today announced that its Board of Directors has authorized the Company to amend its bylaws to adopt procedures relating to shareholder nominations for the election of directors.

26 Oct 2009

German based LIFEBRIDGE AG receives FDA clearance for mobile LIFEBRIDGE

German based LIFEBRIDGE AG has received clearance from the U.S. Food and Drug Administration (FDA) for a compact, lightweight, mobile heart-lung machine, a first for any manufacturer worldwide.

26 Oct 2009

Dey Pharma launches EpiPen Auto-Injector

Dey Pharma, L.P., a subsidiary of Mylan Inc., today launched a newly designed, patient-friendly EpiPen® Auto-Injector 0.3/0.15 mg. This next-generation EpiPen Auto-Injector maintains the simplicity, speed, safety and reliability of EpiPen Auto-Injector with several new, user-friendly features, including being the only auto-injector with needle-protection before and after use.

26 Oct 2009

Third-quarter financial results announced by Roper Industries

Roper Industries, Inc. reported financial results for the third quarter ended September 30, 2009.

26 Oct 2009

American Heart Association joins international organizations to fight the global threat of stroke

During this year's observance of "World Stroke Day," Thursday, October 29, the American Heart Association and its division, the American Stroke Association, will join international organizations with a unified message about the global threat of stroke.

26 Oct 2009

Tru-flo urinary catheter valve from ProtekMed

ProtekMed has launched the Tru-flo(TM) urinary catheter valve, an innovative and economical alternative to the standard tube and bag system prescribed by most urologists today.

26 Oct 2009

Montreal Children's Hospital inaugurates Brain Suite intraoperative MRI

The Montreal Children's Hospital inaugurates its new Brain Suite, home to the first intraoperative magnetic resonance (MRI) in a Canadian pediatric hospital and the first in Quebec.

26 Oct 2009

First physician affiliated with Renaissance Health Systems goes live with PWeR

The Quantum Group, Inc. announced today that the first physician affiliated with Quantum subsidiary Renaissance Health Systems has “gone live” with PWeR™ (Personal Wellness electronic Record™), the one patient, one record™ electronic medical record platform offered by Quantum Innovations, Inc.

26 Oct 2009

Medical News

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

Tart cherry juice may help runners recover quickly and effectively from post-race pain

HealthSouth announces credit agreement amendment and extended maturity of a portion of its term loan

StayinFront signs agreements with two leading biopharma companies to deploy StayinFront EdgeRx

ADA Technologies to develop home lithiummonitor for patients with bipolar disorder

Phase 2a clinical trial in nonsense mutation hemophilia A and hemophilia B initiated

Ontario Lung Association partners with Health Canada for radon gas awareness campaign

CMSC analyses patient self-management in Multiple Sclerosis

Results from Phase I dose-escalation study of AT-101 announced

Allegheny Technologies acquires Crucible Compaction Metals and Crucible Research for $40.95 million

Rexahn Pharmaceuticals completes Registered Direct Offering of common stock and warrants

Dysport, a new wrinkle fighter, available now in the United States

HealthSouth to reimburse shareholder expenses for proxy solicitation campaign

German based LIFEBRIDGE AG receives FDA clearance for mobile LIFEBRIDGE

Dey Pharma launches EpiPen Auto-Injector

Third-quarter financial results announced by Roper Industries

American Heart Association joins international organizations to fight the global threat of stroke

Tru-flo urinary catheter valve from ProtekMed

Montreal Children's Hospital inaugurates Brain Suite intraoperative MRI

First physician affiliated with Renaissance Health Systems goes live with PWeR

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News